Page 3 - டெல்ஹி அனைத்தும் இந்தியா நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Highlights The AIIMS chief further said that studies have shown that plasma therapy has a limited role and is not of much use. “Remdesivir should only be given to patients who are hospitalised, had fall in oxygen saturation and have infiltrates on the chest X-ray or CT-scan, said Guleria. New Delhi: Delhi All India Institute Of Medical Sciences (AIIMS) chief Dr Randeep Guleria on Monday (April 19) said that anti-viral Remdesivir and plasma therapy have a limited role to play in the treatment of COVID-19 infected patients and are not of much use. During a press conference, the AIIMS director stressed that Remdesivir injections should be administered to only critical COVID-19 infected patients. 

New delhiRandeep guleriaDelhi all india instituteCovid 19Elhi aiims chiefRandeep guleriaPlasma therapyElhi covid 19புதியது டெல்ஹிரந்தீப் குலேரியாடெல்ஹி அனைத்தும் இந்தியா நிறுவனம்